home / stock / dtcff / dtcff news

DTCFF News and Press, Defence Therapeutics Inc Cl A From 05/17/22

Stock Information
Company Name: Defence Therapeutics Inc Cl A
Stock Symbol: DTCFF
Market: OTC
Website: defencetherapeutics.com
Menu
DTCFF DTCFF Quote DTCFF Short DTCFF News DTCFF Articles DTCFF Message Board
Get DTCFF Alerts

News, Short Squeeze, Breakout and More Instantly...
DTCFF - Defence Novel AccuVAC-PTE7 Vaccine Shows Complete Protection from Cervical Cancer

Vancouver, British Columbia--(Newsfile Corp. - May 17, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceuticals company primarily focussed on the development of novel immune-oncology vaccines and drug deliver...
DTCFF - Defence Therapeutics receives U.S. patent for vaccine platform technology

Defence Therapeutics (OTCPK:DTCFF) said the United States Patent and Trademark Office (USPTO) had granted a patent number to its vaccine platform technology for the treatment and prevention of a wide range of cancers and infectious diseases, including COVID-19. The patent number '717 wil...

DTCFF - Defence Therapeutics Announces Issuance Of a U.S. Patent Covering Its Pioneering Vaccine Platform Technology

Vancouver, British Columbia--(Newsfile Corp. - April 7, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company primarily focused on the development of novel vaccines and drug delivery technologies, is ple...

DTCFF - Defence Therapeutics: An Anti-Cancer Solutions Platform Company Advancing Its Versatile Accum Technology

Vancouver, British Columbia--(Newsfile Corp. - March 22, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF)(" Defence " or the " Company "), a Canadian biotech company actively working on accelerating scientific discoveries and products development against cancer, is ple...
DTCFF - Defence Releases Peer-Reviewed Publication of Its Preclinical Data on AccuVAC-D001L In Cell Reports Medicine Journal

Vancouver, British Columbia--(Newsfile Corp. - February 28, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a pre-clinical biotechnology company developing various products for the immune-oncology space, is pleased to announce the pub...

DTCFF - Defence Retains CATO SMS to Advise on Its Phase I Clinical Trial on AccuTOX(TM) for Breast Cancer

Vancouver, British Columbia--(Newsfile Corp. - February 16, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a pre-clinical biotechnology company developing various products for the immune-oncology space, is pleased to announce the est...

DTCFF - Defence's Accum(TM)-HPV Vaccine Formulation (AccuVAC-PT009) Activates a 36-Fold Higher Humoral Response Compared to Gardasil-9

Vancouver, British Columbia--(Newsfile Corp. - January 26, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a pre-clinical biotechnology company developing various immune-oncology products, is pleased to announce the development of Acc...
DTCFF - Defence Therapeutics Achieves a Major Milestone and Begins IND-Enabling Testing of Its AccuTOX Lead Compound Against Breast Cancer

Vancouver, British Columbia--(Newsfile Corp. - January 10, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a pre-clinical biotechnology company developing various immune-oncology products, is pleased to announce the start of its final...

DTCFF - Defence Therapeutics Accum(TM) Boosts by 9-Fold the Delivery Effectiveness of the CRISPR/Cas9 Protein to Target Cells

Vancouver, British Columbia--(Newsfile Corp. - December 13, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company focused on the development of vaccines and therapeutics against cancer and infectious diseases, is ple...

DTCFF - Defence Therapeutics Vaccines and Program Development

Vancouver, British Columbia--(Newsfile Corp. - November 30, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), is a publicly-traded biotechnology company working on engineering the next generation vaccines, Antibody Drug Conjugates, ADC ...
Previous 10 Next 10